Korean Journal of Family Medicine (가정의학회지)

The Korean Academy of Family Medicine (대한가정의학회)
권호 표지
DOI QR코드

DOI QR Code

The Diagnostic Criteria of Metabolic Syndrome and the Risk of Coronary Heart Disease according to Definitions in Men

성인 남성에서 대사증후군 진단도구별 유병률과 관상동맥질환 발생위험도

  • Seo, Hyouk-Soo (Department of Family Medicine, Daegu Catholic University Medical Center) ;
  • Kim, Sung-Hi (Department of Family Medicine, Daegu Catholic University Medical Center) ;
  • Park, Soon-Woo (Department of Family Medicine, Daegu Catholic University Medical Center) ;
  • Kim, Jong-Yeon (Department of Family Medicine, Daegu Catholic University Medical Center) ;
  • Lee, Geon-Ho (Department of Family Medicine, Daegu Catholic University Medical Center) ;
  • Lee, Hye-Mi (Department of Family Medicine, Daegu Catholic University Medical Center)
  • 서혁수 (대구가톨릭대학병원 가정의학과) ;
  • 김성희 (대구가톨릭대학병원 가정의학과) ;
  • 박순우 (대구가톨릭대학병원 가정의학과) ;
  • 김종연 (대구가톨릭대학병원 가정의학과) ;
  • 이건호 (대구가톨릭대학병원 가정의학과) ;
  • 이혜미 (대구가톨릭대학병원 가정의학과)
  • Received : 2008.09.20
  • Accepted : 2010.02.25
  • Published : 2010.03.20
⟨ Previous Next ⟩

Abstract

Background: Early detection of metabolic syndrome (MS) is important to prevent complications. Yet, there is no internationally agreed definition for MS. This study was performed to compare the diagnostic criteria of MS using various definitions and agreements, and to find better definition for screening high risk group of coronary heart disease. Methods: The participants were 426 men above forty years old who had visited to have health screening in a general hospital in Daegu from March to December in 2007. The diagnostic criteria of MS and Kappa statistic were calculated according to the following five diagnostic definitions; modified World Health Organization (WHO), National Cholesterol Education Program Third Adult Treatment Panel (NCEP-ATP III), International Diabetes Federation (IDF), American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI) and NCEP-ATP III modified waist circumference ${\geq}$ 90 cm (modified NCEP-ATP III). The sensitivity and specificity of each definition of MS were calculated with respect to high risk group by Framingham risk score (FRS). Results: The diagnostic criteria of MS were 6.6% by IDF, 7.7% by WHO, 10.6% by NCEP-ATP III, 18.1% by modified NCEPATP III and 22.3% by AHA/NHLBI. The kappa satistic ranged from 0.30 to 0.87. The sensitivity of each definition with respect to FRS was 8.3% in IDF, 13.4% in WHO, 15.3% in NCEP-ATP III, 27.4% in modified NCEP-ATP III and 32.5% in AHA/NHLBI. Conclusion: There was great difference in the diagnostic criteria of MS according to diagnostic definitions. The author suggests that AHA/NHLBI or modified NCEP-ATP III definition may be better for screening high risk group of coronary heart disease than others.

연구배경: 대사증후군 합병증을 예방하기 위해 대사증후군의 조기 진단이 중요하지만, 국제적인 진단기준의 일치가 없는 상황이다. 이 연구는 대사증후군의 진단도구별 유병률과 각각의 일치도를 비교하고 관상동맥질환 고위험군 선별에 어느 진단도구가 더 유용한지 알아보기 위해 실시되었다. 방법: 2007년 3월부터 12월까지 대구광역시 소재 일개 대학병원종합검진센터에서 종합검진을 받은 40세 이상의 남성 426 명을 대상으로 하였다. 5가지 진단도구; 수정된 World Health Organization (WHO), National Cholesterol Education Program Third Adult Treatment Panel (NCEP-ATP III), International diabetes Federation (IDF), American Heart Association/National Heart, Lung and Blood Institute (AHA/NHLBI), 그리고 세계보건기구 아시아-태평양기준에 따라 허리둘레가 수정된 NCEPATP III (modi ed NCEP-ATP III)에 따른 유병률과 일치율을 펴보았다. 또한 Framingham risk score (FRS)를 이용하여 구해진 고위험군과 각 진단도구별 민감도 및 특이도를 구하였다. 결과: 대사증후군의 유병률은 WHO에서 7.7%, NCEP-ATP III 에서 10.6%, IDF에서 17.8%, 수정된 NECP-ATPIII에서 18.1%, AHA/NHLBI에서 27.2%였다. 진단도구 간의 일치율은 0.30에서 0.88까지 나타났다. FRS에 대한 진단도구별 민감도는 WHO에서 13.4%, NCEP-ATP III에서 15.3%, IDF에서 24.8%, 수정된 NCEP-ATP III에서 27.4%, AHA/NHLBI에서 32.5%였다. 결론: 진단도구별 대사증후군 유병률 차이는 컸다. 관상동맥 질환 고위험군 선별 측면에서 AHA/NHLBI 및 수정된 NCEPATP III, IDF가 다른 진단도구보다 좋았다.

Keywords

References

  1. Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-607. https://doi.org/10.2337/diabetes.37.12.1595
  2. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94. https://doi.org/10.2337/diacare.14.3.173
  3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53. https://doi.org/10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
  4. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22. https://doi.org/10.2337/diabetes.41.6.715
  5. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third Natio nal Health and Nutrition Examination Survey. JAMA 2002;287: 356-9. https://doi.org/10.1001/jama.287.3.356
  6. Thomas GN, Ho SY, Janus ED, Lam KS, Hedley AJ, Lam TH, et al. The US national cholesterol education programme adult treatment panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract 2005;67:251-7. https://doi.org/10.1016/j.diabres.2004.07.022
  7. Western Pacific Region of World Health Organization, International Association for the Study of Obesity. The Asia- Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Austrailia Pty Ltd.; 2000.
  8. Park HS, Oh SW, Kang JH, Park YW, Choi JM, Kim YS, et al. Prevalence and associated factors with metabolic syndrome in South Korea: from the Korean National Health and Nutrition Examination Survey, 1998. J Korean Soc Study Obes 2003;12:1-14.
  9. Park HS, Shin HC, Kim BS, Lee KY, Choi WS, Shin JA, et al. Prevalence and associated factors of metabolic syndrome among adults in primary care. J Korean Soc Study Obes 2003;12:108-23.
  10. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9. https://doi.org/10.2337/diacare.24.4.683
  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-97. https://doi.org/10.1001/jama.285.19.2486
  12. Korea National Statistical Office. Death and causes of death in 2006. Daejeon: Korea National Statistical Office; 2007.
  13. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001;44:1148-54. https://doi.org/10.1007/s001250100615
  14. Saar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-9. https://doi.org/10.1161/01.CIR.0000080897.52664.94
  15. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). ird report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421.
  16. Zimmer P, Alberti G, Shaw J. A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabetes Voice 2005;50:31-4.
  17. LaMonte MJ, Barlow CE, Jurca R, Kampert JB, Church TS, Blair SN. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women. Circulation 2005;112:505-12. https://doi.org/10.1161/CIRCULATIONAHA.104.503805
  18. Santos AC, Barros H. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Diab Vasc Dis Res 2007;4:320-7. https://doi.org/10.3132/dvdr.2007.059
  19. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16. https://doi.org/10.1001/jama.288.21.2709
  20. Lee JS, Jung MH, Lee MS, Yoo BC, Lee YH. Comparison of the prevalence of the metabolic syndrome using two proposed definitions . Kosin Med J 2007;22:34-42.
  21. Won JC, Park JY, Song KH, Lee WJ, Koh EH, Nam-Goong IS, et al. Changes in the prevalence of metabolic syndrome in a rural area of Korea defined by two criteria, revised National Cholesterol Education Program and International Diabetes Federation. J Korean Diabetes Assoc 2007;31:284-92. https://doi.org/10.4093/jkda.2007.31.3.284
  22. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005;165:2644-50. https://doi.org/10.1001/archinte.165.22.2644
  23. Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW. Prevalence of the metabolic syndrome as defined by NCEPATP III among the urban Korean population. Korean J Med 2002;63:290-8.
  24. Deepa M, Farooq S, Daa M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34). Diabetes Metab Res Rev 2007;23:127-34. https://doi.org/10.1002/dmrr.658
  25. Guerrero-Romero F, Rodriguez-Moran M. Concordance between the 2005 International Diabetes Federation definition for diagnosing metabolic syndrome with the National Chole sterol Education Program Adult Treatment Panel III and the World Health Organization definitions. Diabetes Care 2005;28:2588-9. https://doi.org/10.2337/diacare.28.10.2588
  26. Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, et al. The prevalence and clinical characteristics of the metabolic syndrome in middle-aged Korean adults. Korean J Med 2005;68:359-68.
  27. von Birgelen C, Hartmann M, Mintz GS, van Houwelingen KG, Deppermann N, Schmermund A, et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 2004;110:1579-85. https://doi.org/10.1161/01.CIR.0000142048.94084.CA
  28. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association; European Association for the Study of Diabetes. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-304. https://doi.org/10.2337/diacare.28.9.2289